Health system operating margins tumbled into negative territory at the start of 2026 before gradually recovering and the recovery, while real, didn’t play out evenly. Strata Decision Technology’s Performance Trends Report for H1 2026 draws on financial and operational data from more than 2,200 hospitals to examine how margins, expenses and patient volumes moved through the first six months of the year.
Erik Wexler, president and CEO of Providence in Renton, Wash., identified the structural tension underlying the numbers. “The most dangerous trend in healthcare today is the widening disconnect between the demands placed on the healthcare system and the resources available to meet them,” Mr. Wexler told Becker’s.
The Strata data puts that disconnect in detail. Here are seven findings from the report.
1. Margins went negative in January before recovering through June. After a relatively stable second half of 2025, when median health system operating margins held in the +1.0% to +1.5% range, systems entered 2026 in the red. The median margin dropped to -0.6% in January and -0.3% in February before turning positive by March and climbing to +0.7% by June. The trajectory reflects improvement but underscores how constrained margins remain, even as patient volumes continued to grow throughout the period.
Robin Damschroder, executive vice president and CFO at Henry Ford Health in Detroit, offered a stark assessment of what the environment demands.
“Incremental improvements are not going to get us there,” Ms. Damschroder told Becker’s. “We need to make major investments in clinical care and operations, especially as AI implementation surges within the healthcare industry, creating opportunities to significantly reduce administrative burdens and improve care delivery.”
2. Labor and supply costs are roughly flat. Across all four census regions, labor and supply expense per entity-adjusted patient day held largely steady over the past year. The standout is the West, which ran roughly 50% above the Midwest, Northeast and South throughout the period. The gap that held consistent month to month, pointing to structural cost differences rather than a short-term fluctuation.
3. Drug costs tell a different regional story. Unlike labor and supply, pharmaceutical expenses don’t track neatly by geography. The Midwest and Northeast generally reported the highest drug expense per entity-adjusted patient day, while the South remained lowest and most stable. Strata noted that clinical utilization patterns, 340B program participation, payer mix and regulatory factors all influence drug costs, making it difficult to pin the variation to any single driver.
4. Bigger hospitals consistently spend more per patient day, even after adjusting for volume. Across labor, supply and drug categories, expense per entity-adjusted patient day increased with bed size. Hospitals with more than 500 beds consistently posted the highest per-patient-day costs; those with 25 beds or fewer, the lowest. Because the metric is normalized for patient activity, size alone doesn’t explain the gap. Instead, differences in acuity, service mix, academic and tertiary capabilities, staffing models and purchasing scale all likely contribute to the variation.
5. The inpatient-to-outpatient revenue split looks fundamentally different by size. Hospitals with more than 500 beds consistently generated nearly half their gross operating revenue from inpatient care. Among hospitals with 25 beds or fewer, that share dropped to roughly 10%, with outpatient activity accounting for the large majority of revenue. Midwest hospitals had the lowest inpatient revenue share and the highest outpatient revenue share of the four census regions.
6. Outpatient migration is raising the acuity of patients who remain hospitalized. Service lines where more than 90% of volume now occurs in outpatient settings are seeing inpatient case mix index rise. The dynamic is a predictable consequence of the shift: as lower-acuity cases migrate to ambulatory settings, the patients who remain hospitalized are, on average, more complex and resource intensive. Strata found inpatient CMI changes of roughly 1% to 3% year over year from Q1 2024 through 2026, a gradual change with real financial and capacity implications.
7. Service lines are diverging sharply within the same environment. Two service lines illustrate how differently volume and complexity can move within the same market. Breast health inpatient volumes rose 17.2% in H1 2026 — the largest increase among tracked service lines — alongside the steepest CMI gain, at 3.21%, consistent with rising diagnostic rates and more complex surgical patterns. Gynecology moved the other direction, as inpatient volumes fell 8%, a trend the report connects to the ongoing migration of hysterectomy procedures to outpatient settings as minimally invasive and robotic techniques have expanded.
The divergence reinforces the report’s argument that margin management has no single playbook. James Hereford, president and CEO of Fairview Health Services in Minneapolis, says there is a standard systems should hold themselves to when evaluating growth.
“Every dollar of growth should strengthen our financial footing and make care easier, safer and more personal for the communities we serve,” Mr. Hereford told Becker’s.
